Found: 51
Select item for more details and to access through your institution.
A Case Report of a Patient With Pulmonary Arterial Hypertension Transitioned From Inhaled Iloprost to Selexipag.
- Published in:
- Journal of Pharmacy Practice, 2021, v. 34, n. 6, p. 980, doi. 10.1177/0897190020958242
- By:
- Publication type:
- Article
Effects of Tolvaptan, a Vasopressin Antagonist, in Patients Hospitalized With Worsening Heart Failure: A Randomized Controlled Trial.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 291, n. 16, p. 1963, doi. 10.1001/jama.291.16.1963
- By:
- Publication type:
- Article
Clinical Differences and Outcomes between Methamphetamine-associated and Idiopathic Pulmonary Arterial Hypertension in the Pulmonary Hypertension Association Registry.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Editorial: REVEALing the Score.
- Published in:
- 2012
- By:
- Publication type:
- Editorial
Noninvasive Imaging in the Evaluation of Pulmonary Hypertension.
- Published in:
- Current Medical Literature: Pulmonary Hypertension, 2011, v. 2, n. 1, p. 1
- By:
- Publication type:
- Article
Risk Assessment in Pulmonary Arterial Hypertension Patients: The Long and Short of it.
- Published in:
- Advances in Pulmonary Hypertension, 2018, v. 16, n. 3, p. 125, doi. 10.21693/1933-088x-16.3.125
- By:
- Publication type:
- Article
Ambulatory Hemodynamic Monitoring in the Management of Pulmonary Arterial Hypertension.
- Published in:
- Advances in Pulmonary Hypertension, 2014, v. 13, n. 2, p. 81, doi. 10.21693/1933-088x-13.2.81
- By:
- Publication type:
- Article
Concomitant cat scratch disease and squamous cell carcinoma in a cardiac transplant.
- Published in:
- Infectious Disease Reports, 2012, v. 4, n. 1, p. 3, doi. 10.4081/idr.2012.e2
- By:
- Publication type:
- Article
Aggressive Afterload Lowering to Improve the Right Ventricle: A New Target for Medical Therapy in Pulmonary Arterial Hypertension?
- Published in:
- 2022
- By:
- Publication type:
- journal article
Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2021, v. 203, n. 6, p. E1
- By:
- Publication type:
- Article
Enrichment Benefits of Risk Algorithms for Pulmonary Arterial Hypertension Clinical Trials.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Challenges in Pulmonary Hypertension: Controversies in Treating the Tip of the Iceberg. A Joint National Institutes of Health Clinical Center and Pulmonary Hypertension Association Symposium Report.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Risk Assessment Tools in Pulmonary Arterial Hypertension. Prognosis for Prospective Trials?
- Published in:
- 2018
- By:
- Publication type:
- Editorial
Enhancing Insights into Pulmonary Vascular Disease through a Precision Medicine Approach. A Joint NHLBI-Cardiovascular Medical Research and Education Fund Workshop Report.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Endothelin-1 Pathway Polymorphisms and Outcomes in Pulmonary Arterial Hypertension.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Computational Simulator Models and Invasive Hemodynamic Monitoring as Tools for Precision Medicine in Pulmonary Arterial Hypertension.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 1, p. 82, doi. 10.3390/jcm11010082
- By:
- Publication type:
- Article
Pulmoner arter hipertansiyonu: Epidemiyoloji ve kayıtlar.
- Published in:
- Archives of the Turkish Society of Cardiology / Türk Kardiyoloji Derneği Arşivi, 2014, v. 42, n. Supp 1, p. 1
- By:
- Publication type:
- Article
Risk assessment in patients with functional class II pulmonary arterial hypertension: Comparison of physician gestalt with ESC/ERS and the REVEAL 2.0 risk score.
- Published in:
- PLoS ONE, 2020, v. 15, n. 11, p. 1, doi. 10.1371/journal.pone.0241504
- By:
- Publication type:
- Article
European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 4, p. 469, doi. 10.1002/ejhf.2830
- By:
- Publication type:
- Article
Serum Endostatin Is a Genetically Determined Predictor of Survival in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 2, p. 208, doi. 10.1164/rccm.201409-1742OC
- By:
- Publication type:
- Article
Supplement: Serum Endostatin is a Genetically Determined Predictor of Survival in Pulmonary Arterial Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2015, v. 191, n. 2, p. E1, doi. 10.1164/rccm.201409-1742oc
- By:
- Publication type:
- Article
Transition from Intravenous Epoprostenol to Intravenous Treprostinil in Pulmonary Hypertension.
- Published in:
- American Journal of Respiratory & Critical Care Medicine, 2005, v. 172, n. 12, p. 1586, doi. 10.1164/rccm.200505-766OC
- By:
- Publication type:
- Article
Safety and efficacy of RT234 vardenafil inhalation powder on exercise parameters in pulmonary arterial hypertension: phase II, dose-escalation study design.
- Published in:
- Respiratory Research, 2022, v. 23, n. 1, p. 1, doi. 10.1186/s12931-022-02262-9
- By:
- Publication type:
- Article
The nitric oxide–soluble guanylate cyclase–cGMP pathway in pulmonary hypertension: from PDE5 to soluble guanylate cyclase.
- Published in:
- European Respiratory Review, 2024, v. 33, n. 171, p. 1, doi. 10.1183/16000617.0183-2023
- By:
- Publication type:
- Article
Riociguat and the right ventricle in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension.
- Published in:
- European Respiratory Review, 2022, v. 31, n. 166, p. 1, doi. 10.1183/16000617.0061-2022
- By:
- Publication type:
- Article
Management of Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction.
- Published in:
- Current Hypertension Reports, 2014, v. 16, n. 12, p. 1, doi. 10.1007/s11906-014-0501-5
- By:
- Publication type:
- Article
Tissue Doppler Assessment of Longitudinal Right and Left Ventricular Strain and Strain Rate in Pulmonary Artery Hypertension.
- Published in:
- Echocardiography, 2006, v. 23, n. 10, p. 872, doi. 10.1111/j.1540-8175.2006.00337.x
- By:
- Publication type:
- Article
Exercise capacity and haemodynamics in patients with sickle cell disease with pulmonary hypertension treated with bosentan: results of the ASSET studies.
- Published in:
- British Journal of Haematology, 2010, v. 149, n. 3, p. 426, doi. 10.1111/j.1365-2141.2010.08097.x
- By:
- Publication type:
- Article
Reply.
- Published in:
- Annals of the American Thoracic Society, 2015, v. 12, n. 6, p. 960, doi. 10.1513/annalsats.201505-263le
- By:
- Publication type:
- Article
Perspectives on Oral Pulmonary Hypertension Therapies Recently Approved by the U.S. Food and Drug Administration.
- Published in:
- Annals of the American Thoracic Society, 2015, v. 12, n. 2, p. 269, doi. 10.1513/AnnalsATS.201501-020AS
- By:
- Publication type:
- Article
A Novel Compound, “FA-1” Isolated from Prunus mume, Protects Human Bronchial Epithelial Cells and Keratinocytes from Cigarette Smoke Extract-Induced Damage.
- Published in:
- Scientific Reports, 2018, v. 8, n. 1, p. 1, doi. 10.1038/s41598-018-29701-2
- By:
- Publication type:
- Article
CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
- Published in:
- Pulmonary Circulation, 2024, v. 14, n. 1, p. 1, doi. 10.1002/pul2.12323
- By:
- Publication type:
- Article
INSPIRE: Safety and tolerability of inhaled Yutrepia (treprostinil) in pulmonary arterial hypertension (PAH).
- Published in:
- Pulmonary Circulation, 2022, v. 12, n. 3, p. 1, doi. 10.1002/pul2.12119
- By:
- Publication type:
- Article
TORREY, a Phase 2 study to evaluate the efficacy and safety of inhaled seralutinib for the treatment of pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2021, v. 11, n. 4, p. 1, doi. 10.1177/20458940211057071
- By:
- Publication type:
- Article
Assessment of the REPLACE study composite endpoint in riociguat-treated patients in the PATENT study.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020973124
- By:
- Publication type:
- Article
Pulmonary vasodilators: beyond the bounds of pulmonary arterial hypertension therapy in COVID-19.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020970369
- By:
- Publication type:
- Article
Residence at moderately high altitude and its relationship with WHO Group 1 pulmonary arterial hypertension symptom severity and clinical characteristics: the Pulmonary Hypertension Association Registry.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020964342
- By:
- Publication type:
- Article
Comparative effectiveness of endothelin receptor antagonists on mortality in patients with pulmonary arterial hypertension in a US Medicare population: a retrospective database analysis.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020954158
- By:
- Publication type:
- Article
Safety and efficacy of transitioning from the combination of bosentan and sildenafil to alternative therapy in patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 4, p. 1, doi. 10.1177/2045894020945523
- By:
- Publication type:
- Article
Switching to riociguat: a potential treatment strategy for the management of CTEPH and PAH.
- Published in:
- Pulmonary Circulation, 2020, v. 10, n. 1, p. 1, doi. 10.1177/2045894019837849
- By:
- Publication type:
- Article
United States Pulmonary Hypertension Scientific Registry (USPHSR): rationale, design, and clinical implications.
- Published in:
- Pulmonary Circulation, 2019, v. 9, n. 2, p. N.PAG, doi. 10.1177/2045894019851696
- By:
- Publication type:
- Article
Association between cytokines and functional, hemodynamic parameters, and clinical outcomes in pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2018, v. 8, n. 3, p. 1, doi. 10.1177/2045894018794051
- By:
- Publication type:
- Article
Bosentan‐based, treat‐to‐target therapy in patients with pulmonary arterial hypertension: results from the COMPASS‐3 study.
- Published in:
- Pulmonary Circulation, 2018, v. 8, n. 1, p. 1, doi. 10.1177/2045893217741480
- By:
- Publication type:
- Article
Replacing a phosphodiesterase-5 inhibitor with riociguat in patients with connective tissue disease-associated pulmonary arterial hypertension: a case series.
- Published in:
- Pulmonary Circulation, 2017, v. 7, n. 3, p. 741, doi. 10.1177/2045893217721694
- By:
- Publication type:
- Article
Phosphodiesterase type 5 inhibitor to riociguat transition is associated with hemodynamic and symptomatic improvement in pulmonary hypertension.
- Published in:
- Pulmonary Circulation, 2017, v. 7, n. 2, p. 539, doi. 10.1177/2045893217708566
- By:
- Publication type:
- Article
MicroCT analysis of vascular morphometry: a comparison of right lung lobes in the SUGEN/hypoxic rat model of pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2017, v. 7, n. 2, p. 522, doi. 10.1177/2045893217709001
- By:
- Publication type:
- Article
Three-dimensional micro computed tomography analysis of the lung vasculature and differential adipose proteomics in the Sugen/hypoxia rat model of pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 586, doi. 10.1086/688931
- By:
- Publication type:
- Article
In situ expression of Bcl-2 in pulmonary artery endothelial cells associates with pulmonary arterial hypertension relative to heart failure with preserved ejection fraction.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 551, doi. 10.1086/688774
- By:
- Publication type:
- Article
Hemodynamic response to treatment of iron deficiency anemia in pulmonary arterial hypertension: longitudinal insights from an implantable hemodynamic monitor.
- Published in:
- Pulmonary Circulation, 2016, v. 6, n. 4, p. 616, doi. 10.1086/688670
- By:
- Publication type:
- Article
Transitioning from parenteral treprostinil to inhaled treprostinil in patients with pulmonary arterial hypertension.
- Published in:
- Pulmonary Circulation, 2013, v. 3, n. 1, p. 116, doi. 10.4103/2045-8932.109926
- By:
- Publication type:
- Article